18 BlackRock Abbvie Trades
BlackRock acquired 151M Abbvie shares worth $33.9B. That's 0.52% of their equity portfolio (26th largest holding). The investor owns 8.82% of the outstanding Abbvie stock. The first Abbvie trade was made in Q4 2020. Since then BlackRock bought shares ten more times and sold shares on seven occasions. The stake costed the investor $17.2B, netting the investor a gain of 98% so far.
News about Abbvie Inc and BlackRock
AbbVie Inc (ABBV) Stock Up 3.6% but GF Value Says Overvalued -- GF Score: 86/100
On April 30, 2026, AbbVie Inc (ABBV) shares rose 3.6% to a current price of $211.32. This movement is notable considering the stock has seen a 52-week high of $
AbbVie: Balancing Potential Acquisition Impact With Positive Q1 2026 Earnings
AbbVie's price might have been sluggish in 2026 so far, but can the latest results change anything? Yes and no. No, because there's acquisition talk doing th...
AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
MONTREAL, April 30, 2026 (GLOBE NEWSWIRE) -- AbbVie (NYSE: ABBV), jointly with adMare BioInnovations, today recognized RIME Therapeutics as the recipient of ...
Price Prediction: Why AbbVie's Post-Humira Pivot Makes It a Strong Buy
Our AbbVie (NYSE:ABBV | ABBV Price Prediction) call lands on the constructive side of the ledger after a noisy but encouraging Q1 earnings report.